Category: Replacement Heart Valves
QT Vascular acquires the Java technology for aortic valvuloplasty in transcatheter aortic valve implants for an undisclosed amount.
QT Vascular said it acquired a new technology platform created by an undisclosed developer in Israel called Java that it plans to develop as an aortic valvuloplasty balloon for transcatheter aortic valve implants.
Medtronic launches a clinical trial to study a new replacement heart valve designed to be surgically implanted in patients with severe aortic stenosis.
Medtronic (NYSE:MDT) today said it launched a clinical trial for a new replacement heart valve designed for patients with severe narrowing of the aortic valve.
Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.
Medtronic reports positive data from a study evaluating an alternative implantation procedure for its CoreValve aortic valve-replacement device.
An FDA advisory panel recommends that CryoLife's heart valve, the CryoValve allograft, be subject to its most-stringent pre-market approval protocol.
Sorin announces the first U.S. implant of its recently approved Solo Smart aortic heart valve.
Sorin Group (BIT:SRN) said that a patient in Indianapolis was the first U.S. recipient of its recently approved Solo Smart aortic heart valve.
Claret Medical launches a pivotal U.S. trial for its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.
Claret Medical said today that the 1st patient has been treated in a U.S. pivotal trial of its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.